[go: up one dir, main page]

EP3976814A1 - Procédés d'identification de composants dans des séquences d'acides nucléiques - Google Patents

Procédés d'identification de composants dans des séquences d'acides nucléiques

Info

Publication number
EP3976814A1
EP3976814A1 EP20814921.1A EP20814921A EP3976814A1 EP 3976814 A1 EP3976814 A1 EP 3976814A1 EP 20814921 A EP20814921 A EP 20814921A EP 3976814 A1 EP3976814 A1 EP 3976814A1
Authority
EP
European Patent Office
Prior art keywords
pol
polymerase
nanostructure
dna
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20814921.1A
Other languages
German (de)
English (en)
Other versions
EP3976814A4 (fr
Inventor
Peiming Zhang
Ming Lei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Sequencing Technology Corp
Original Assignee
Universal Sequencing Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universal Sequencing Technology Corp filed Critical Universal Sequencing Technology Corp
Publication of EP3976814A1 publication Critical patent/EP3976814A1/fr
Publication of EP3976814A4 publication Critical patent/EP3976814A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3278—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/50—Detection characterised by immobilisation to a surface
    • C12Q2565/531—Detection characterised by immobilisation to a surface characterised by the capture moiety being a protein for target oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/607—Detection means characterised by use of a special device being a sensor, e.g. electrode
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8827—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores

Definitions

  • Embodiments of the present invention are related to methods and biochemical materials for an electronic sequencing device to read out individual nucleotides in a nucleic acid sequence using enzymes.
  • a prior art discloses a method to detect the nucleotide incorporation into DNA by monitoring the conformational changes of a DNA polymerase labeled with fluorescent dyes. Depending on the enzymes and dyes, different nucleotides, including those naturally occurring and modified, produced different amplitudes and durations for the fluorescent emissions. The method determines a nucleotide sequence from an ensemble of nucleic acid molecules.
  • a prior art application (WO 2016/183218) claims that a mixture in which one or more of the native nucleotide triphosphates is replaced with an analog having a non natural moiety that alters signal polarity in a distinguishable way without hurting the ability of the analog to base pair with its cognate nucleotide in a template strand during sequencing.
  • a-thio-dATP results in a negative change in signal polarity
  • 2-thio-dTTP results in a positive change in signal polarity so that they can be used to distinguish between the T and A in a template by means of the said device charge sensor (see Figure 2 for their structures).
  • TS transition state
  • Figure 1 a prior art device composed of a carbon nanotube attached to two electrodes (source and drain) and functionalized with a DNA polymerase for monitoring the enzyme activity in real-time.
  • Figure 2 Chemical structure of modified nucleotides a-thio-dATP and 2-thio- dTTP.
  • Figure 3 A schematic diagram of a single molecule DNA sequencing device with polymerase on a nanostructure attached to two electrodes, (a) a DNA
  • nanostructure (b) a peptide nanostructure.
  • Figure 4 (a) Free energy profile for single nucleotide incorporation by different DNA polymerase Pol b WT, R258A mutant, KF, and Pol X; (b) Qualitative free energy profile of matched and mismatched dNTP incorporation by Pol b versus I260Q mutant.
  • Figure 5 the reaction in incorporating a nucleotide substrate to a DNA chain.
  • Figure 7 Chemical structures of naturally occurring nucleoside g-substituted triphosphates.
  • Figure 8 Chemical structures of b, g-C analogies of naturally occurring nucleoside triphosphates.
  • Figure 9 Chemical structures of naturally occurring nucleoside a-thio- triphosphates (a-thio-dNTP).
  • Figure 10 Chemical structures of naturally occurring nucleoside a-borano- triphosphates (a-borano-dNTP).
  • Figure 1 1 Chemical structures of naturally occurring nucleoside a-borano-a- thio-tri phosphates (a-borano-a-thio-dNTPs).
  • Figure 12 Chemical structures of naturally occurring nucleoside a-seleno- triphosphates (a-seleno-dNTP).
  • Figure 13 Chemical structures of naturally occurring deoxyribonucleoside a- R-phosphonyl-b, g-diphosphates.
  • Figure 14 Chemical structures of naturally occurring nucleoside
  • Figure 15 Chemical structures of naturally occurring nucleoside
  • Figure 17 Chemical structures of representative xeno nucleic acid (XNA) nucleosides.
  • Figure 18 Diagram of Watson-Crick base pairs and modification sites in this invention.
  • Figure 19 Chemical structures of modified pyrimidine nucleobases.
  • Figure 20 Chemical structures of modified purine nucleobases.
  • This invention includes a biopolymer nanostructure coupling with a DNA polymerase as an electronic sensor for nucleic acid sequencing (see Figure 3a, a DNA nanostructure, and Figure 3b, a peptide nanostructure), as disclosed in the provisional patent applications, US 62/794,096, US 62/812,736, US 62/833,870, and
  • Both the DNA nanostructure and peptide nanostructure illustrated in Figure 3 are conductors of electron charges under certain conditions through tunneling and hopping.
  • a DNA polymerase is attached to the nanostructure at the predefined locations, each through a short flexible linker.
  • the DNA polymerase first forms a binary complex with a target-primer duplex, existing in an“open” conformation, which can, in turn, form a ternary complex with a correct nucleoside triphosphate through the Watson-Crick base pairing.
  • the ternary complex turns the DNA polymerase to a“closed” conformation, facilitating the elongation reaction.
  • This invention provides methods and chemicals for identifying individual components (or units or bases) that constitute biopolymers, especially DNAs and RNAs.
  • DNAs and RNAs For example, to sequence a target DNA molecule, we use it as a template for DNA synthesis on the said nanostructure sequencing device, with which nucleoside triphosphate substrates are incorporated into a growing DNA strand following the Watson Crick base pairing rule. The DNA sequence is determined by reading the nucleotide incorporation.
  • a recent study has shown that the DNA synthesis is a two Mg 2+ ion assisted stepwise associative SN2 reaction, 6 albeit a third divalent metal ion may be present during DNA synthesis.
  • pyrophosphate (PPi) group released from the SN2 reaction is hydrolyzed to phosphates during the DNA synthesis catalyzed by DNA polymerases.
  • a general mechanism of DNA polymerization is illustrated in Figure 5.
  • the terminal 3’ oxygen of the growing strand acts as a
  • this invention provides modified nucleotide substrates, which affect the kinetics of the polymerase enzymatic reactions in ways different from the naturally occurring nucleotides, generating distinguishable electric signals in the nanostructure that can be used to differentiate individual nucleotides in the target DNA template so that the target DNA can be sequenced.
  • the DNA polymerases used in this invention include those that have been classified by structural homology into the families of A, B, C, D, X, Y, and RT. For example, those in Family A include T7 DNA polymerase and Bacillus
  • RT reverse transcriptase family of DNA polymerases include, for example, retrovirus reverse transcriptases and eukaryotic telomerases.
  • a polymerase is attached to the nanostructure, fed with a duplex composed of DNA primer and a target to be sequenced, and followed by a mixture of nucleoside triphosphates or dNTPs.
  • the DNA polymerase incorporates the dNTPs into the DNA primer according to the Watson-Crick pairing rule, and each incorporating step evokes an electric spike that is recorded in the sensor.
  • nucleoside triphosphate mixtures include: • 0-4 of naturally occurring nucleoside triphosphates ( Figure 6).
  • the substituents are either electron donating or electron withdrawing groups that affect the activities of DNA polymerases, 8 and also may affect the hydrolysis of pyrophosphate to phosphates, resulting in altered reaction rates and, in turn, the electric signals.
  • the Sp-diastereomers of deoxyribonucleoside and ribonucleoside 5'-0-(1 -thio-triphosphates) are analogs of the naturally occurring nucleotides and are incorporated readily into nucleic acids by DNA or RNA polymerases. 12 ’ 13
  • a-borano-dNTPs • 0-4 of a-borano-dNTPs ( Figure 10).
  • the a-borano-dNTPs and a-borano- NTPs are good to excellent substrates for DNA and RNA polymerases, allowing for ready enzymatic syntheses of DNA and RNA. 14 ⁇ 15
  • the said nucleoside triphosphates include modified sugars.
  • Figure 16 shows one form of the modifications, in which the oxygen in the sugar ring is replaced by another atom. These atoms have different electron negativities, which would affect the pK a of the neighbor 3’-OH, and in turn its nucleophilicity.
  • dSNTPs 2'-deoxy-4'-thioribonucleoside 5'-triphosphate
  • X S
  • R H
  • Base A
  • C, G, T with unmodified triphosphate
  • An RNA dependent RNA polymerase (RdRP) is attached to the DNA nanostructure device for RNA sequencing.
  • the enzyme is polio virus RdRP and others.
  • the said nucleoside triphosphates have the nucleoside units including artificial genetic polymer xeno nucleic acids (XNA), a set of nucleic acid polymers with their backbone structures distinct from those found in nature, which is capable of specifically base pairing with DNA nucleobases ( Figure 17).
  • XNAs genetic polymer xeno nucleic acids
  • Figure 17 Some of XNAs have their sugar units flexible or rigid conformations, and others have different configurations and structures from their naturally occurring counterparts. These make their binding to targets in the enzyme differently from those naturally occurring counterparts.
  • some XNAs carry an electron-donating or withdrawing group that make its neighbor OH more or less nucleophilic, compared to the naturally occurring counterpart.
  • TNA can be incorporated into a DNA primer by a laboratory evolved polymerase that derives from a replicative B-family polymerase isolated from the archaeal hyperthermophilic species Thermococcus kodakarensis (Kod). 20 21 These XNA substrates are useful to distinguish a specific DNA nucleotide from the rest of them in a DNA target.
  • the RNA polymerase attached to the biopolymer nanostructure sensor for RNA sequencing includes, but not limited to, viral RNA polymerases such as T7 RNA polymerase; Eukaryotic RNA polymerases such as RNA polymerase I, RNA polymerase II, RNA polymerase III, RNA polymerase IV, and RNA polymerase V; and Archaea RNA polymerase.
  • viral RNA polymerases such as T7 RNA polymerase
  • Eukaryotic RNA polymerases such as RNA polymerase I, RNA polymerase II, RNA polymerase III, RNA polymerase IV, and RNA polymerase V
  • Archaea RNA polymerase Archaea RNA polymerase.
  • the RNA polymerase attached to sensor is fed with a mixture of canonical ribonucleoside triphosphates for reading out RNA sequences.
  • the said mixture contains 0-4 of canonical ribonucleoside triphosphates.
  • This invention further provides modified bases to further tune both DNA and RNA polymerase for their reactivities.
  • These compounds have a common feature of the preserved Watson-Crick hydrogen bonding edges for inserting a correct incoming nucleotide to interact with the template following the Watson-Crick base pairing rule and hydrogen bonding acceptor sites for a polymerase to interact with the base pair from the minor groove. 22 ’ 23
  • the modifications do not disturb the fidelity of the enzyme.
  • the said nucleoside triphosphates are composed of the pyrimidine bases with their 5- positions modified with a series of electron- withdrawing groups, electron donor groups, as well as ethyl, ethylene, and acetylene, to which various functional groups are attached ( Figure 19). These modifications allow us to tune the transition state of the enzymatic reaction.
  • the said nucleoside triphosphates are composed of the purines bases with their 7- positions modified with a series of electron-withdrawing groups, electron donor groups, as well as ethyl, ethylene, and acetylene, to which various functional groups are attached ( Figure 20). These modifications allow us to tune the transition state of the enzymatic reaction.
  • the nucleoside triphosphates are composed of the said modified bases, modified sugars or sugar analogies, and modified triphosphates or triphosphate analogies.
  • a plurality of nanostructure sensors are used to read the nucleic acid sequences in parallel.
  • a plurality of nanostructure sensors can be fabricated in an array format with the number of nanostructure sensors from 10 to 10 9 on a solid surface or in a well, preferably 10 3 to 10 7 or more preferably 10 4 to 10 6 .
  • All of the nanostructure sensors in the said array is configured with one type of nucleic acid polymerase or different types of nucleic acid polymerases.
  • the target sample can be double or single-stranded, linear, or circular DNA.
  • the target sample can also be double or single-stranded, linear, or circular RNA.
  • the primer for the sequencing can be DNA, RNA, conjugates of DNA and RNA, or DNA containing modified nucleosides.
  • a polymerase can be attached to a biopolymer nanostructure sensor at a predefined location or locations using the attachments chemistries provided in the previous provisional patent applications (ref. US 62/794,096, US 62/812,736, US 62/833,870, and US62/803,100).
  • a DNA nanostructure is functionalized with organic functional groups at the predefined DNA nucleoside or nucleosides.
  • the DNA polymerase is bioengineered to contain unnatural amino acids that bear the function against those in the DNA nanostructure for the click reaction.
  • the biopolymer nanostructure in all the above descriptions is replaced by a solid nanowire made of material selected from the group of platinum (Pt), palladium (Pd), Tungsten (W), gold (Au), copper (Cu), titanium (Ti), Tantalum (Ta), Chromium (Cr), TiN, TiNx, TaN, TaNx, silver (Ag), aluminum (Al), and other metals, preferably Pt, Pd, Au, Ti, and TiN.
  • the nanowire is 3nm to 10pm in length, preferably 20nm to 1 pm; 5nm to 50nm in width, preferably 5nm to 20nm; and 3nm to 50nm in thickness, preferably 4nm to 10nm.
  • the nanowire is a carbon nanotube or a graphene sheet, single layer or multilayer, with dimension similar to the nanowire.
  • the nanostructure in all the above descriptions is replaced by a molecular wire, such as those disclosed in patent applications,
  • WO2018208505 US20180305727A1
  • WO2018136148A1 All the nucleoside triphosphate and ribonucleoside triphosphate designs, modifications, variations, natural or unnatural, their interaction with polymerase, their methods of use and principles of distinguishing individual nucleotides apply to the polymerase-molecular wire coupled DNA/RNA sequencing system.
  • a DNA polymerase is directly attached to the two electrodes, bridging the nanogap between the two electrodes and allowing electrons or electric current to pass through, such as those disclosed in patent applications
  • a FET type polymerase sequencing system such as those disclosed in the provisional patent application US62/833,870.
  • a FET type polymerase sequencing system such as those disclosed in the provisional patent application US62/833,870.
  • the mechanism of polymerase conformational change affecting the electrical signal passing through the nanogap is somehow different, the nucleoside triphosphate and ribonucleoside triphosphate designs, modifications, variations, natural or unnatural, and their interaction with polymerase, their methods of use and principles of distinguishing individual nucleotides also apply to the FET type polymerase DNA/RNA sequencing system.
  • Cited Literature Patents or patent applications are incorporated into where they are mentioned in the text.
  • the cited journal publications are listed in Cited Literature.
  • SHAW B. R.; DOBRIKOV, M.; WANG, X.; WAN, J.; HE, K.; LIN, J.-L; LI, P.; RAIT, V.; SERGUEEVA, Z. A.; SERGUEEV, D., Reading, Writing, and Modulating

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Human Computer Interaction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La présente invention concerne des procédés d'identification ou de séquençage d'une molécule d'ADN ou d'ARN électroniquement à un niveau moléculaire unique sur la base de la synthèse de la polymérase.
EP20814921.1A 2019-05-27 2020-05-27 Procédés d'identification de composants dans des séquences d'acides nucléiques Pending EP3976814A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853119P 2019-05-27 2019-05-27
US201962861675P 2019-06-14 2019-06-14
PCT/US2020/034759 WO2020243207A1 (fr) 2019-05-27 2020-05-27 Procédés d'identification de composants dans des séquences d'acides nucléiques

Publications (2)

Publication Number Publication Date
EP3976814A1 true EP3976814A1 (fr) 2022-04-06
EP3976814A4 EP3976814A4 (fr) 2023-07-19

Family

ID=73552680

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20814921.1A Pending EP3976814A4 (fr) 2019-05-27 2020-05-27 Procédés d'identification de composants dans des séquences d'acides nucléiques

Country Status (6)

Country Link
US (1) US20220251638A1 (fr)
EP (1) EP3976814A4 (fr)
JP (1) JP2022535746A (fr)
KR (1) KR20220012920A (fr)
CN (1) CN114555832A (fr)
WO (1) WO2020243207A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020257654A1 (fr) 2019-06-20 2020-12-24 Arizona Board Of Regents On Behalf Of Arizona State University Lecture électrique directe de séquences d'acides nucléiques
US11913070B2 (en) 2020-02-28 2024-02-27 Arizona Board Of Regents On Behalf Of Arizona State University Methods for sequencing biopolymers
US12351855B2 (en) 2019-01-30 2025-07-08 Arizona Board Of Regents On Behalf Of Arizona State University Bioelectronic circuits, systems and methods for preparing and using them
US12480937B2 (en) 2018-05-17 2025-11-25 Recognition AnalytiX, Inc. Device, system and method for direct electrical measurement of enzyme activity

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019217600A1 (fr) 2018-05-09 2019-11-14 Stuart Lindsay Procédé de détection et de quantification électroniques d'anticorps
US12298300B2 (en) 2020-04-17 2025-05-13 Arizona Board Of Regents On Behalf Of Arizona State University Single-molecule electronic sequence detector and methods of use
CN116018413A (zh) 2020-05-29 2023-04-25 代表亚利桑那大学的亚利桑那校董事会 具有可编程适配子的生物电子装置
AU2023202006B1 (en) * 2022-08-15 2023-07-13 Micromole Inc. System, Apparatus and Process

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005254984B2 (en) * 2004-06-10 2008-10-16 Ge Healthcare Bio-Sciences Corp. Method for nucleic acid analysis
JP2010035451A (ja) * 2008-08-01 2010-02-18 Toray Ind Inc タグ配列、タグ配列固定化バイオチップおよびタグ配列を用いた選択結合性物質の検出方法
US9238836B2 (en) * 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
GB2557509A (en) * 2012-06-08 2018-06-20 Pacific Biosciences California Inc Modified base detection with nanopore sequencing
WO2014194246A1 (fr) * 2013-05-30 2014-12-04 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Molécule lecteur universelle pour reconnaissance à effet tunnel
RU2721965C2 (ru) * 2014-12-18 2020-05-25 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Обнаружение изменений конформации полимеразы нуклеиновых кислот с помощью нанотрубки
US9618474B2 (en) * 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
CA2984112C (fr) * 2015-05-12 2021-07-06 Illumina, Inc. Appareil a effet de champ et procedes de sequencage d'acides nucleiques
CA3021580A1 (fr) * 2015-06-25 2016-12-29 Barry L. Merriman Capteurs biomoleculaires et procedes associes
WO2017024017A1 (fr) * 2015-08-06 2017-02-09 Pacific Biosciences Of California, Inc. Systèmes et procédés pour l'adressage sélectif de dispositifs de mesure électroniques agencés de façon clairsemée
CN109416334B (zh) * 2016-01-14 2021-11-16 罗斯韦尔生物技术股份有限公司 分子传感器及相关方法
WO2017132586A1 (fr) * 2016-01-28 2017-08-03 Roswell Biotechnologies, Inc. Procédé et appareil pour mesurer des analytes à l'aide de réseaux de capteurs à électronique moléculaire à grande échelle
JP2019515317A (ja) * 2016-04-27 2019-06-06 クオンタムバイオシステムズ株式会社 バイオ分子の測定およびシーケンシングのためのシステムおよび方法
US20190376925A1 (en) * 2016-11-22 2019-12-12 Roswell Biotechnologies, Inc. Nucleic acid sequencing device containing graphene
CN110546276A (zh) * 2017-04-25 2019-12-06 罗斯威尔生命技术公司 用于分子传感器的酶电路

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12480937B2 (en) 2018-05-17 2025-11-25 Recognition AnalytiX, Inc. Device, system and method for direct electrical measurement of enzyme activity
US12351855B2 (en) 2019-01-30 2025-07-08 Arizona Board Of Regents On Behalf Of Arizona State University Bioelectronic circuits, systems and methods for preparing and using them
WO2020257654A1 (fr) 2019-06-20 2020-12-24 Arizona Board Of Regents On Behalf Of Arizona State University Lecture électrique directe de séquences d'acides nucléiques
EP3986908A4 (fr) * 2019-06-20 2023-07-19 Arizona Board of Regents on behalf of Arizona State University Lecture électrique directe de séquences d'acides nucléiques
US11913070B2 (en) 2020-02-28 2024-02-27 Arizona Board Of Regents On Behalf Of Arizona State University Methods for sequencing biopolymers

Also Published As

Publication number Publication date
JP2022535746A (ja) 2022-08-10
KR20220012920A (ko) 2022-02-04
CN114555832A (zh) 2022-05-27
EP3976814A4 (fr) 2023-07-19
WO2020243207A1 (fr) 2020-12-03
US20220251638A1 (en) 2022-08-11

Similar Documents

Publication Publication Date Title
US20220251638A1 (en) Methods to Identify Components in Nucleic Acid Sequences
US20230175039A1 (en) Closed nucleic acid structures
US20220290234A1 (en) DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS)
EP3620533B1 (fr) Structures d'acide nucléique fermée
AU2012304520B2 (en) Circularized templates for sequencing
CN107109466A (zh) 使用纳米管的核酸聚合酶构象变化的检测
US10253352B2 (en) Methods for determining sequence profiles
Yang et al. Correlation of the kinetics of finger domain mutants in RB69 DNA polymerase with its structure
Bhamra et al. Base-pairing preferences, physicochemical properties and mutational behaviour of the DNA lesion 8-nitroguanine
Stengel et al. Ambivalent incorporation of the fluorescent cytosine analogues tC and tCo by human DNA polymerase α and Klenow fragment
Jung et al. Nucleotide analogues as probes for DNA polymerases
Hu et al. Specificity enhancement of deoxyribonucleic acid polymerization for sensitive nucleic acid detection
EP2744916A1 (fr) Méthodes multimodales de détection et de quantification simultanées de plusieurs acides nucléiques dans un échantillon
Cho et al. Use of nucleotide analogs by class I and class II CCA-adding enzymes (tRNA nucleotidyltransferase): Deciphering the basis for nucleotide selection
US20080096765A1 (en) Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction
HK40005350A (en) Detection of nucleic acid polymerase conformational changes using a nanotube
TW200530396A (en) Methods for identifying SNPs

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211129

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230616

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 27/447 20060101ALI20230612BHEP

Ipc: B82Y 15/00 20110101ALI20230612BHEP

Ipc: G01N 33/00 20060101ALI20230612BHEP

Ipc: C12Q 1/68 20180101AFI20230612BHEP